The Foundation is guided by a set of vital objectives: Establish standardized protocols for the immediate treatment of spinal injuries, ensuring accessibility across various locations. Provide funding for grants tailored to support show jumping athletes who sustain spinal injuries while actively engaged in Show Jumping. These grants aim to facilitate consultations with top-tier medical professionals at leading healthcare facilities. Our charter is dedicated to this specific group of athletes. Allocate resources to support the development and promotion of cutting-edge safety equipment within the equestrian community. We recognize that our sport lags in this area and are committed to exploring innovative options in safety vests and riding coats that are readily available. Collaborate with national equestrian federations and competitions to educate equestrian show jumping athletes about the importance of available safety equipment, thus enhancing protection against catastrophic injuries.
Reported officers (all unpaid)
No paid executives reported in 2023. KEVIN BABINGTON FOUNDATION reported 4 unpaid officers and board members on its 990.
What Diseases, Disorders & Medical Disciplines executives earn in Massachusetts
KEVIN BABINGTON FOUNDATION reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization in Massachusetts earns a median of $127,066.
These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 88 organizations across 88 filings (2022 – 2024).
See full Diseases, Disorders & Medical Disciplines pay data for Massachusetts →Common questions about KEVIN BABINGTON FOUNDATION
What are KEVIN BABINGTON FOUNDATION's revenue and expenses?
In 2023, KEVIN BABINGTON FOUNDATION reported $530k in total revenue and $987k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.